Thymosin Beta-4
Full-Length Thymosin for Comprehensive Tissue Repair
Thymosin Beta-4 is the full-length 43-amino-acid protein responsible for actin regulation, cell migration, and tissue regeneration. It supports healing of muscle, tendon, cardiac, and connective tissue through multiple regenerative pathways.
Starting at
$179/mo
2-in-1
Peptide Blend
Dual
Mechanism
SC
Administration
$199
Per Vial
How Thymosin Beta-4 Works
The full-length protein that regulates actin and drives comprehensive tissue repair
BPC-157: Local Repair
Promotes angiogenesis and growth factor expression at injury sites for targeted tissue regeneration.
TB-500: Systemic Healing
Thymosin Beta-4 fragment promotes cell migration, reduces inflammation systemically, and supports new blood vessel formation.
Synergistic Effect
The combination addresses both local and systemic healing pathways, potentially accelerating recovery beyond either peptide alone.
Why Choose Thymosin?
Accelerated Tissue Repair
Dual-peptide approach targets multiple healing pathways simultaneously.
Reduced Inflammation
Both peptides contribute anti-inflammatory effects through different mechanisms.
Enhanced Mobility
May support faster return to function after musculoskeletal injuries.
Comprehensive Recovery
Addresses both local injury site and systemic healing environment.
Gut Protection
BPC-157 component provides additional gastrointestinal protective benefits.
Connective Tissue Support
TB-500 supports actin regulation for cellular repair and tissue remodeling.
BPC-157 / TB-500 Protocol
Provider-customized dosing for optimal recovery
BPC 250mcg + TB 750mcg daily
Loading phase — establish therapeutic levels
BPC 250mcg + TB 750mcg daily
Active healing phase — monitor progress
Taper as directed
Maintenance or completion based on recovery
Expected Results Timeline
All dosing determined by your prescribing provider. Individual results vary.
Frequently Asked Questions
BPC-157 excels at local tissue repair through angiogenesis, while TB-500 works systemically to reduce inflammation and promote cell migration. Together they provide comprehensive recovery support.
The BPC-157/TB-500 combination is widely used in clinical peptide therapy. Your provider will assess your medical history to ensure it's appropriate for you.
Many patients report reduced pain within 1-2 weeks, with progressive improvement over 4-8 weeks. Results depend on the type and severity of injury.
Yes, this combination is commonly used for both acute and chronic musculoskeletal conditions. Your provider will tailor the protocol to your specific situation.
Start Thymosin Beta-4 Therapy
Full-length Thymosin Beta-4 for comprehensive tissue repair. Prepared by US-licensed 503A pharmacies.
Get Started NowFree medical consultation included • Cancel anytime